Free Trial
→ SpaceX eyes a 1.75 trillion valuation - here's what to know (From Brownstone Research) (Ad)tc pixel Free URGN Stock Alerts

Urogen Pharma (URGN) Institutional Ownership

Urogen Pharma logo
$29.68 -1.26 (-4.07%)
Closing price 04:00 PM Eastern
Extended Trading
$29.64 -0.04 (-0.12%)
As of 04:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Urogen Pharma (NASDAQ:URGN)

Current
Institutional Ownership
Percentage
91.29%
Number of
Institutional Buyers
(last 12 months)
93
Total
Institutional Inflows
(last 12 months)
$410.86M
Number of
Institutional Sellers
(last 12 months)
52
Total
Institutional Outflows
(last 12 months)
$132.01M
Get URGN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Urogen Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

URGN Institutional Buying and Selling by Quarter

Urogen Pharma Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/13/2026Cetera Investment Advisers29,096$523K0.0%-3.3%0.060%
5/7/2026 Swiss National Bank77,800$1.40M0.0%N/A0.160%
4/29/2026 Meitav Investment House Ltd.22,223$400K0.0%-37.4%0.046%
4/16/2026 SG Americas Securities LLC1,657,846$29.81M0.0%+20.3%3.406%
3/20/2026 Hsbc Holdings PLC10,316$236K0.0%-25.7%0.021%
2/19/2026 Invesco Ltd.27,066$634K0.0%+21.1%0.058%
2/18/2026XTX Topco Ltd22,491$527K0.0%-23.2%0.048%
2/18/2026Voloridge Investment Management LLC435,490$10.20M0.0%-36.7%0.930%
2/18/2026Susquehanna Portfolio Strategies LLC27,380$641K0.0%N/A0.058%
2/18/2026Tang Capital Management LLC350,000$8.20M0.4%-65.0%0.748%
2/18/2026Superstring Capital Management LP718,354$16.82M9.0%+717.1%1.535%
2/18/2026Orbimed Advisors LLC875,487$20.50M0.4%+27.1%1.870%
2/18/2026Opaleye Management Inc.268,423$6.29M0.8%N/A0.573%
2/18/2026Millennium Management LLC618,952$14.50M0.0%-59.1%1.322%
2/18/2026Main Street Financial Solutions LLC20,990$492K0.0%-34.8%0.045%
2/18/2026Elmind Capital LP100,000$2.34M0.7%N/A0.214%
2/18/2026Cinctive Capital Management LP16,991$398K0.0%N/A0.036%
2/17/2026AQR Capital Management LLC153,413$3.59M0.0%-24.9%0.328%
2/17/2026Cetera Investment Advisers30,096$705K0.0%-6.2%0.064%
2/17/2026MPM Bioimpact LLC941,378$22.05M2.5%+597.3%2.011%
2/17/2026Paradigm Biocapital Advisors LP4,473,648$104.77M2.7%+6.1%9.557%
2/17/2026Jump Financial LLC17,900$419K0.0%-82.8%0.038%
2/17/2026Price T Rowe Associates Inc. MD616,606$14.44M0.0%+72.9%1.317%
2/17/2026Diadema Partners LP21,810$511K0.1%-75.8%0.047%
2/17/2026 Russell Investments Group Ltd.47,257$1.11M0.0%+1,323.0%0.101%
2/17/2026Atom Investors LP234,423$5.49M0.4%-19.7%0.501%
2/17/2026ExodusPoint Capital Management LP35,393$829K0.0%+113.9%0.076%
2/17/2026Royal Bank of Canada8,391$196K0.0%-81.5%0.018%
2/17/2026 Persistent Asset Partners Ltd12,806$300K0.1%-38.2%0.027%
2/17/2026Rice Hall James & Associates LLC281,876$6.60M0.4%+8.8%0.602%
2/16/2026Squarepoint Ops LLC22,831$535K0.0%N/A0.049%
2/16/2026Panagora Asset Management Inc.74,055$1.73M0.0%-59.8%0.158%
2/16/2026 MML Investors Services LLC24,363$571K0.0%N/A0.052%
2/16/2026Healthcare of Ontario Pension Plan Trust Fund1,125,100$26.35M0.0%N/A2.404%
2/16/2026Barclays PLC57,744$1.35M0.0%+3.8%0.123%
2/13/2026Marshall Wace LLP16,300$382K0.0%-12.7%0.035%
2/13/2026The Manufacturers Life Insurance Company 55,686$1.29M0.0%+55.0%0.119%
2/13/2026Morgan Stanley2,562,901$60.02M0.0%+1.4%5.475%
2/13/2026State Street Corp807,421$18.91M0.0%-1.5%1.725%
2/13/2026 Wells Fargo & Company MN84,158$1.97M0.0%-33.2%0.180%
Your book is inside (Ad)

The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel

Download your copy now.
2/12/2026HRT Financial LP130,899$3.07M0.0%-2.1%0.280%
2/12/2026Orion Porfolio Solutions LLC9,008$211K0.0%-18.2%0.019%
2/12/2026Renaissance Technologies LLC244,300$5.72M0.0%-11.2%0.522%
2/12/2026Annandale Capital LLC60,552$1.42M0.2%-14.2%0.129%
2/12/2026Informed Momentum Co LLC160,412$3.76M0.4%N/A0.343%
2/12/2026 New York State Common Retirement Fund12,737$298K0.0%+62.5%0.027%
2/12/2026 Nuveen LLC302,601$7.09M0.0%-40.4%0.646%
2/11/2026 ARK Investment Management LLC121,484$2.85M0.0%-4.1%0.260%
2/11/2026 Deutsche Bank AG366,680$8.59M0.0%+126.0%0.783%
2/11/2026Franklin Resources Inc.16,745$392K0.0%N/A0.036%
2/11/2026JPMorgan Chase & Co.146,271$3.43M0.0%-72.6%0.312%
2/11/2026 WINTON GROUP Ltd13,188$309K0.0%N/A0.028%
2/10/2026 TD Asset Management Inc80,188$1.88M0.0%+82.2%0.171%
2/10/2026Goldman Sachs Group Inc.459,722$10.77M0.0%+8.2%0.982%
2/10/2026 Intech Investment Management LLC22,210$520K0.0%+45.9%0.047%
2/9/2026Geode Capital Management LLC475,212$11.13M0.0%+0.8%1.015%
2/6/2026 ProShare Advisors LLC8,812$206K0.0%N/A0.019%
2/5/2026DNB Asset Management AS16,961$397K0.0%N/A0.036%
2/3/2026 Privium Fund Management B.V.214,622$5.03M0.9%+9.2%0.458%
2/2/2026 Oppenheimer & Co. Inc.16,962$397K0.0%N/A0.036%
1/29/2026 UBS Group AG235,040$5.51M0.0%+30.2%0.502%
1/29/2026 China Universal Asset Management Co. Ltd.7,627$179K0.0%-5.9%0.016%
1/26/2026 Mirae Asset Global Investments Co. Ltd.2,275$53K0.0%+27.2%0.005%
1/23/2026 Oak Ridge Investments LLC85,230$2.00M0.1%-2.6%0.182%
1/14/2026Hennion & Walsh Asset Management Inc.161,924$3.79M0.1%+148.4%0.346%
1/9/2026 SG Americas Securities LLC1,377,647$32.26M0.0%+19.0%2.943%
1/1/2026JPMorgan Chase & Co.534,545$10.66M0.0%+36.9%1.142%
11/17/2025Jacobs Levy Equity Management Inc.21,376$426K0.0%N/A0.046%
11/17/2025TCG Crossover Management LLC717,347$14.31M0.7%N/A1.532%
11/17/2025XTX Topco Ltd29,302$585K0.0%N/A0.063%
11/17/2025Voloridge Investment Management LLC687,475$13.72M0.0%N/A1.469%
11/17/2025Verition Fund Management LLC89,028$1.78M0.0%N/A0.190%
11/17/2025Paradigm Biocapital Advisors LP4,216,084$84.11M2.4%N/A9.007%
11/17/2025Parkman Healthcare Partners LLC402,595$8.03M0.8%+127.8%0.860%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.17,017$339K0.0%-15.8%0.036%
11/17/2025HighVista Strategies LLC31,886$636K0.2%N/A0.068%
11/17/2025Farallon Capital Management LLC11,000$219K0.0%N/A0.023%
11/17/2025Bank of America Corp DE108,454$2.16M0.0%-59.1%0.232%
11/14/2025 Creative Planning10,444$208K0.0%N/A0.022%
11/14/2025Schonfeld Strategic Advisors LLC297,851$5.94M0.0%+36.3%0.636%
11/14/2025Man Group plc10,780$215K0.0%-24.5%0.023%
11/14/2025Orbimed Advisors LLC689,000$13.75M0.3%+44.0%1.472%
11/14/2025Two Sigma Investments LP386,203$7.71M0.0%+103.9%0.825%
11/13/2025Jump Financial LLC103,866$2.07M0.0%N/A0.222%
11/13/2025Annandale Capital LLC70,552$1.41M0.2%-6.6%0.151%
11/13/2025 UBS Group AG180,460$3.60M0.0%-41.5%0.386%
11/13/2025 BNP Paribas Financial Markets308,328$6.15M0.0%+328.7%0.659%
11/13/2025 Russell Investments Group Ltd.3,321$66K0.0%+1,594.4%0.007%
11/13/2025Jefferies Financial Group Inc.2,199,652$43.88M0.2%-1.3%4.699%
11/12/2025Barclays PLC55,619$1.11M0.0%-20.7%0.119%
Distracted Americans set to miss out on quadrillions (Ad)

Technology expert and Washington D.C. insider Jeff Brown - who identified Bitcoin, Tesla, and Nvidia early - says hundreds of trillions of dollars are about to move through a new financial technology that has nothing to do with AI. Goldman Sachs, Citi, Chase, and 50-plus major institutions are already preparing. A key piece of legislation expected before July could fast-track global adoption. Jeff is sharing his full research at no charge.tc pixel

Click here to see Jeff Brown's full research before July
11/12/2025Orion Porfolio Solutions LLC11,008$220K0.0%N/A0.024%
11/12/2025HAP Trading LLC19,806$271K0.0%N/A0.042%
11/12/2025 ARK Investment Management LLC126,720$2.53M0.0%-23.7%0.271%
11/12/2025 Intech Investment Management LLC15,227$304K0.0%-19.4%0.033%
11/12/2025 Fox Run Management L.L.C.16,902$337K0.1%N/A0.036%
11/10/2025 TD Asset Management Inc44,000$878K0.0%-17.6%0.094%
11/10/2025Ameritas Investment Partners Inc.3,082$61K0.0%-19.6%0.007%
11/10/2025 China Universal Asset Management Co. Ltd.8,109$162K0.0%-12.4%0.017%
11/10/2025 Persistent Asset Partners Ltd20,726$413K0.3%-40.1%0.044%
11/7/2025NEOS Investment Management LLC50,458$1.01M0.0%N/A0.109%


URGN Institutional Ownership - Frequently Asked Questions

During the previous two years, 152 institutional investors and hedge funds held shares of Urogen Pharma. The most heavily invested institutionals were Paradigm Biocapital Advisors LP ($104.77M), Morgan Stanley ($60.02M), UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC ($48.23M), Jefferies Financial Group Inc. ($43.88M), RTW Investments LP ($40.84M), RA Capital Management L.P. ($35.46M), and Cowen AND Company LLC ($35.23M).Learn more on Urogen Pharma's institutional investors.

91.29% of Urogen Pharma's stock is owned by institutional investors. Learn more on URGN's institutional investor holdings.

Of the 132 institutional investors that purchased Urogen Pharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Paradigm Biocapital Advisors LP ($4.47M), Toronto Dominion Bank ($3.50M), RA Capital Management L.P. ($3.21M), UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC ($3.04M), Soleus Capital Management L.P. ($2.19M), Vestal Point Capital LP ($2.15M), and SG Americas Securities LLC ($1.66M).

Institutional investors have bought a total of 24,333,416 shares in the last 24 months. This purchase volume represents approximately $410.86M in transactions.

Of the 52 institutional investors that sold Urogen Pharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adage Capital Partners GP L.L.C. ($2.10M), Menora Mivtachim Holdings LTD. ($1.15M), Millennium Management LLC ($1.12M), Tang Capital Management LLC ($650K), JPMorgan Chase & Co. ($388.27K), Harel Insurance Investments & Financial Services Ltd. ($291.21K), and Acorn Capital Advisors LLC ($256.55K).

Institutional investors have sold a total of 7,712,643 shares in the last 24 months. This volume of shares sold represents approximately $132.01M in transactions.


Related Companies

This page (NASDAQ:URGN) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Millionaire warns: Move your money now
Larry Benedict, the hedge fund trader who generated $274 million in profits for clients and beat the S&P 500 b...
Brownstone Research | Sponsoredtc pixel
Elon’s Biggest Launch Ever: 15x Bigger Than SpaceX
The Man Who Called Nvidia Before It Soared 1,000% Issues New Elon Musk BUY Alert Luke Lango was ranked Amer...
InvestorPlace | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
You'll buy SpaceX at $1.75 trillion. Insiders bought at $20 billion.
Insiders bought SpaceX at $20 billion. Banks got in at $100 billion. By the time it hits your brokerage accoun...
Behind the Markets | Sponsoredtc pixel
The system holding the dollar together is gone…
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel